The Defense Logistics Agency (DLA) Troop Support Medical awarded a single-award Indefinite Delivery Contract (IDC) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, valued at $999,999,999 through November 2026. This IDC serves as the primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract encompasses critical medical commodities including specialty medications, brand-name and generic drugs, vaccines, syringes, vials, and test kits across multiple therapeutic domains.
In addition, AmerisourceBergen holds a separate IDC with the Department of Justice Federal Bureau of Investigation, valued at $750,000 through May 2024, which covers similar medical products and prescription drugs. These IDCs enable efficient government procurement of essential pharmaceutical and medical supplies, serving the healthcare needs of military personnel, veterans, and other federal beneficiaries through streamlined contracting mechanisms. The original solicitation, SPE2DE-23-R-0005, was issued by DLA Troop Support Medical to establish an alternative to manual market purchases for orthopedic procedural packages, with an estimated value of $269 million over five years.
Generated 1/31/25, 9:10 AM